Sections
Mini Sections
EPIA Business Development Unit Intern – Paid Internship
Interim Public Affairs Manager
Network and CrossLingual Projects Director
Account Executive in Public Affairs - Financial Services Practice
Policy advisor International Affairs
Writer/Web Editor - Native English
Consultant (Scientist) to work on the NERC-funded project "VALOR"
Mettre une annonceLe Parlement s'est prononcé à une écrasante majorité en faveur d'une proposition de directive visant à encourager le développement de médicaments adaptés aux besoins spécifiques des enfants.
The European Parliament plenary has confirmed the Parliament Enviornment Committee's (ENVI) stand (see EurActiv 15 July 2005) and voted in favour of the paediatric medicines directive.
The directive, the aim of which is to guarantee that medicines administered to children are suitable for them, requires pharmaceutical companies to conduct clinical trials involving children before authorisation of drugs. As compensation for these extra costs and as incentive for more R&D, the companies will be granted a six-month extension of their patent.
The Parliament also backed the ENVI Committee's wish to see the European Medicines Agency (EMEA) establish a network of researchers to avoid duplicating research or tests on children and called for the creation of a special EU programme for research into medicines for children, to be called MICE (Medicines Investigation for the Children of Europe).